Allergan, Inc. v. Actavis plc et al, No. 2:14-cv-00638 (E.D. Tex. Dec. 23, 2014)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Before the Court are Defendants’ (Actavis PLC, Actavis, Inc., Watson Laboratories , Inc. and Actavis Pharma, Inc., collectively, “Defendants”) Motions to Dismiss for Lack of Pe rsonal Jurisdiction (-188 Case, Dkt. No. 24 ; -638 Case, Dkt. No. 35) and Plaintiff Allergan, Inc.’s Motions for Summary Judgment on Count I and Motions to Dismiss Count II (-188 Case, Dkt. No. 35; -638 Case Dkt. No. 14) .